Description:
The Market for Rx-to-OTC Switches, 8th Edition provides an in-depth analysis of the dynamic U.S. Rx-to-OTC switch market, which has grown into a double-digit multi-billion-dollar industry driven by patent expirations, increased competitiveness, FDA collaboration, brand reinvention, consumer demand, and cost containment strategies.
Report Highlights:
- Market Dynamics:
- Examination of the transition of over 700 pharmaceutical products from prescription (Rx) to over-the-counter (OTC) status.
- Analysis of how the aging baby boomer population and the pandemic have influenced self-care trends and expanded the Rx-to-OTC market.
- Discussion on the ongoing growth and interest in Rx-to-OTC switch products from both consumers and developers.
- Consumer Behavior:
- Insights into the rising patient-consumer awareness of health issues and the increasing willingness to purchase OTC medicines.
- The impact of cost-saving measures, advertising, and promotions on the rate of OTC purchases.
- Data showing that over one-third of American consumers use an OTC medication at least every other day, with numbers steadily increasing.
Scope and Methodology:
- Market Segmentation:
- Detailed analysis of recent Rx-to-OTC switches and products nearing switch status.
- Market size estimates and forecasts for switched products, reflecting the most up-to-date analysis since Kalorama’s 2017 report.
- Comprehensive Coverage:
- Issues and Trends: Key factors affecting the Rx-to-OTC switch market.
- Leading Participants: Profiles of major players in the OTC industry.
- OTC Market Overview: A look at the broader over-the-counter drug market.
- International Trends: Examination of global Rx-to-OTC switch trends.
- Market by Category:
- Allergy, Cough, Cold, and Sinus Products: Recent switches, market size, forecast, market share, and more.
- Analgesics and Pain Relievers: Detailed analysis of market dynamics.
- Anti-Infectives: Market insights and future outlook.
- Gastrointestinal Drugs: Comprehensive market overview.
- Smoking Cessation Products: Market trends and projections.
- Other Drugs: Market size, forecast, and share analysis.
- Total Market: Overall market size, forecast, and share.
Competitive Landscape:
- Company Coverage:
- Analysis of major companies competing in the Rx-to-OTC switched market, including brand, generic, and private label manufacturers.
- Overview of consolidation trends, strategic alliances, product innovation, line extensions, and promotional strategies driving growth in the industry.
- Profiles of leading competitors offering key brand products.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: The U.S. Market for Rx-to-OTC Switches, by Segment, 2021-2026 (in millions $)
| Segment | 2021 | % | 2026 | % | CAGR 2021-2026 |
| Allergy/Cold/Cough/Sinus | $XX Million | XX% | $XX Million | XX% | XX% |
| Analgesics | $XX Million | XX% | $XX Million | XX% | XX% |
| Infection/Fungal Treatments | $XX Million | XX% | $XX Million | XX% | XX% |
| Gastrointestinal/Digestive | $XX Million | XX% | $XX Million | XX% | XX% |
| Smoking Cessation | $XX Million | XX% | $XX Million | XX% | XX% |
| Others | $XX Million | XX% | $XX Million | XX% | XX% |
| Total | $XX Million | XX% | $XX Million | XX% | XX% |
Source: Kalorama Information
